Impact of Direct Outreach to Expand Access to Naloxone in the Context of Standing Orders
Condition(s):Opioid Abuse; Overdose; Risk BehaviorLast Updated:February 21, 2022Active, not recruiting
Hide Studies Not Open or Pending
Condition(s):Opioid Abuse; Overdose; Risk BehaviorLast Updated:February 21, 2022Active, not recruiting
Condition(s):Opioid OverdoseLast Updated:October 8, 2021Recruiting
Condition(s):NaloxoneLast Updated:May 16, 2022Completed
Condition(s):Pain, Postoperative; Postoperative Nausea and Vomiting; ScoliosisLast Updated:September 10, 2020Completed
Condition(s):Drug Overdose; Opioid-Related DisordersLast Updated:May 17, 2016Unknown status
Condition(s):Opioid Use; Pain, Musculoskeletal; Surgery; Overdose of OpiateLast Updated:May 3, 2021Not yet recruiting
Condition(s):Drug OverdoseLast Updated:August 29, 2018Completed
Condition(s):ConstipationLast Updated:June 24, 2015Completed
Condition(s):Harm Reduction; Opioid-use Disorder; NaloxoneLast Updated:July 19, 2019Completed
Condition(s):Healthy Subjects; Opioid Antagonist; PharmacokineticsLast Updated:July 15, 2022Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.